Graviola
Natural health product licensed in Canada
- Licence holder
- ÉQUILIBRE SANTÉ NATUREL INC.
- NPN or DIN-HM
- 80071004
- Status
- Active licence
- Licence date
- 11 July 2016
- Revision date
- 30 October 2020
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Annona muricata Source : Feuille | 500 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | minimum: 2 days ; maximum: 3 days |
Uses authorised in Canada
Fournit des antioxydants qui aident à combattre les dommages cellulaires causés par les radicaux libres.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Ne pas utiliser ce produit si vous êtes enceinte ou prévoyez le devenir, ou si vous souffrez de la maladie de Parkinson. Ne pas utiliser si vous consommez régulièrement le fruit ou le thé de graviola.
- Précautions et mises en garde
Consulter un praticien de soins de santé avant utilisation si vous allaitez, si vous avez une basse pression artérielle, si vous prenez des médicaments contre l'hypertension ou pour traiter des troubles du c¿ur, des antidépresseurs ou des inhibiteur de MAO.
- Effets indésirables connus
Diminuer la dose ou cesser l'usage si des nausées surviennent. En cas de somnolence ou sédation, cesser l'utilisation du produit.
Source
Official Health Canada record, licence 80071004
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.